Bone and Spine Metastases

Dear Colleagues,

The incidence and prevalence of bone metastases have been rising because cancer-carrying patients have a longer life expectancy owing to recent advances in treatment and diagnosis. Bone metastases can cause pathological fractures, spinal cord compression, and hypercalcemia, leading to serious symptoms including neurological dysfunction and intractable pain. The spine is the most common site of bone metastases, and these symptoms impair the health status and quality of life of patients, the addressal of which is the goal of multidisciplinary treatment for bone and spine metastases. However, there is still room for improvement in the treatment of bone and spine metastases. Further research on surgery, radiotherapy, and systemic treatment, including anti-tumor drugs, molecular targeted drugs, and bone‐modifying agents, is warranted. Additionally, it is extremely valuable to understand the biology of bone metastases and to develop new treatments with fewer and/or less-severe side effects. The goal of this Special Issue is to improve clinical outcomes and propose a new strategy for bone and spine metastases.

You may choose our Joint Special Issue in JCM.

Dr. Kenichiro Kakutani
Dr. Yutaro Kanda
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.